TREATMENT STRATEGIES FOR EXTENSION OF LEVODOPA EFFECT

被引:22
作者
LEWITT, PA [1 ]
机构
[1] WAYNE STATE UNIV, DETROIT, MI 48202 USA
关键词
D O I
10.1016/S0733-8619(18)30224-X
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:511 / 526
页数:16
相关论文
共 112 条
[81]   2 WEEKS OF TREATMENT WITH DEPRENYL (SELEGILINE) DOES NOT PROLONG L-DOPA EFFECT IN PARKINSONIAN-PATIENTS - A DOUBLE-BLIND CROSSOVER PLACEBO-CONTROLLED TRIAL [J].
RASCOL, O ;
MONTASTRUC, JL ;
SENARD, JM ;
DEMONET, JF ;
SIMONETTA, M ;
RASCOL, A .
NEUROLOGY, 1988, 38 (09) :1387-1391
[82]  
Reches A, 1984, Adv Neurol, V40, P171
[83]  
Reilly D K, 1983, Adv Neurol, V37, P51
[84]   MONOAMINE-OXIDASE ACTIVITY AND MONOAMINE METABOLISM IN BRAINS OF PARKINSONIAN-PATIENTS TREATED WITH L-DEPRENYL [J].
RIEDERER, P ;
YOUDIM, MBH .
JOURNAL OF NEUROCHEMISTRY, 1986, 46 (05) :1359-1365
[85]   PLASMA CONCENTRATION OF LEVODOPA IN PATIENTS WITH PARKINSONS-DISEASE - RESPONSE TO ADMINISTRATION OF LEVODOPA ALONE OR COMBINED WITH A DECARBOXYLASE INHIBITOR AND CLINICAL CORRELATIONS [J].
RINNE, UK ;
SONNINEN, V ;
SIIRTOLA, T .
EUROPEAN NEUROLOGY, 1973, 10 (05) :301-310
[86]  
RINNE UK, 1989, ACTA NEUROL SCA S126, V80, P1
[87]  
RINNE UK, 1983, ACTA NEUROL SCAN S95, V68, P1
[88]   L-DOPA TREATMENT FAILURE - EXPLANATION AND CORRECTION [J].
RIVERACA.L ;
DUJOVNE, CA ;
MORGAN, JP ;
LASAGNA, L ;
BIANCHIN.JR .
BRITISH MEDICAL JOURNAL, 1970, 4 (5727) :93-&
[89]   CLINICAL PICTURE AND PLASMA LEVODOPA METABOLITE PROFILE OF PARKINSONIAN NON-RESPONDERS - TREATMENT WITH LEVODOPA AND DECARBOXYLASE INHIBITOR [J].
RIVERACALIMLIM, L ;
TANDON, D ;
ANDERSON, F ;
JOYNT, R .
ARCHIVES OF NEUROLOGY, 1977, 34 (04) :228-232
[90]  
SAARINEN A, 1973, ACTA NEUROL SCAND, V57, P340